<DOC>
	<DOCNO>NCT01621685</DOCNO>
	<brief_summary>In 2004 , investigator initiate human Capsaicin inhalation experiment Investigational New Drug ( IND ) protocol approve FDA ( IND 69,642 ) subject safety procedure institute approved Institutional Review Board ( IRB ) . As part study protocol , inhale Capsaicin solution analyze use high performance liquid chromatography ( HPLC ) . The investigation employ safety procedure conduct human inhalation investigation . In addition , investigation observe discrepancy predict Capsaicin concentration mix registered pharmacist actual capsaicin concentration determine HPLC . The stability Capsaicin solution store seven month period refrigerate 4degrees C protect ultraviolet light examine .</brief_summary>
	<brief_title>Human Safety Capsaicin Inhalation Challenge Testing Young Older Men</brief_title>
	<detailed_description>After research subject 's death inhalation study use medications/drugs approve route , FDA prohibit human use non-approved chemical include capsaicin administer via inhalation . Capsaicin inhalation challenge test ( CICT ) perform forty men different age utilize pharmaceutical grade Capsaicin . Solutions mixed register pharmacist Capsaicin dos , administer subject , analyzed high performance liquid chromatography ( HPLC ) . Capsaicin solution store refrigerator 4 degree C shield ultraviolet light 7 month . There serial monitoring spirometry impulse oscillometry , electrocardiography , blood pressure , pulse oxygen saturation measurement . There adverse reaction dose , include high capsaicin concentration . Serial spirometry impulse oscillometry , electrocardiography , blood pressure , pulse oxygen saturation measurement change . The actual amount pharmaceutical-grade capsaicin measure 85.5 % concentration estimate registered pharmacist time mix . The difference low 0.49 uMol dose ( 28.1 ) compare 2.2 % less concentration 1000 uMol solution . Capsaicin concentration fell 3 month storage . Dilute capsaicin aerosol inhalation relatively innocuous CICT safe . The actual amount pharmaceutical-grade capsaicin inhale subject less estimate mixing . Capsaicin lose potency 3-months protected storage . Inhalation study involve non-approved drug chemicals/medications safely conduct follow appropriate safety procedure describe investigation .</detailed_description>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>1 . Men age 18 30 ( Dates birth 19731985 ) 5592 year old ( Dates birth 19111948 ) . 2 . Must currently cigarette smoker . If exsmoker smoke least 10 year consumption 10 pack year . 3 . Agrees volunteer study willing sign inform consent form . 4 . There negative/normal screening test follow 1 . Responses questionnaire deny current prior respiratory disease ( include asthma , emphysema , chronic bronchitis , sinusitis interstitial lung d9sase ) current respiratory complaint ( e.g. , cough , wheeze , shortness breath , allergic rhinitis , sinusitis ) . Subjects must take cardiac medication admit physiciandiagnosed cardiac condition . 2 . `` Normal '' spirometry measurement FEV1 &amp; FVC great 75 % predict FEV1/FVC 69 % 3 . Impedance oscillometry within normal limit 4 . `` Negative '' physical examination chest absence wheeze crackle auscultation chest . 5 . Exhaled nitric oxide concentration le 35 ppb young less 65 ppb old group 1. men : age &lt; 18 , 3154 &gt; 92 year old ; 2. current cigarette smoker exsmokers smoke within past 10 year and/or smoke 10 pack/years ; 3. refusal volunteer study willing sign inform consent form ; 4. screen test consider `` normal '' physician/PI show one following : 1. one positive response questionnaire ( e.g. , current past respiratory disease include asthma , emphysema , chronic bronchitis , sinusitis interstitial lung disease ; and/or ; current respiratory complaint ( e.g. , cough , wheeze , shortness breath , allergic rhinitis , sinusitis ) and/or ; admit take cardiac medication and/or ; physiciandiagnosed cardiac condition ( e.g. , coronary heart disease , angina , myocardial infarction , valvular heart disease , cardiomyopathy , etc . ) ; 2 . Abnormal spirometry measurement ( FEV1 &amp; /or FVC &lt; 75 % predict FEV1/FVC &lt; 69 % ) ; 3 . `` Positive '' physical examination ( perform Physician/PI ) presence wheeze and/or crackle auscultation chest ; 4 . Impulse oscillometry &gt; 4 time normal limit ; 5 . Exhaled nitric oxide &gt; 35ppb young group &gt; 65 ppb old group .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>92 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Capsaicin</keyword>
	<keyword>Cough</keyword>
	<keyword>Cough reflex</keyword>
	<keyword>Inhalation agent</keyword>
	<keyword>Inhalation challenge</keyword>
	<keyword>TRPV1 receptor</keyword>
</DOC>